Cello Health BioConsulting adds another member to its senior team
Cello Health BioConsulting, the newly-formed strategic management consulting firm focusing on pharmaceuticals, biotechnology and medical device companies in the United States, has announced the appointment of James McDermott as Vice-President.
Jim McDermott joins Cello BioConsulting with over 30
years of experience, with the past 20 focused specifically on the life sciences
industry. During his extensive career,
he has helped hundreds of biotech, pharmaceutical and medical technology
companies with some of their most challenging and important strategic
decisions. He specializes in working
with companies/teams that are seeking fresh thinking on issues such as
commercialization strategy, acquisition/partnership, forecasting/valuation and
strategic planning. Prior to joining
Cello Health BioConsulting he was a senior member of Campbell Alliance’s Corporate
Development Practice and before Campbell he led Decision Resources global consulting
business for over 10 years.
Julia Ralston, CEO
of Cello Health US, commented, “We are delighted to welcome another very senior
and experienced practitioner into the Cello Health BioConsulting team. Jim’s extensive career, broad business
background and therapeutic insight will be a tremendous addition to our team
and is further testament to the growing value of the Cello Health organization
and a significant step in establishing us as one of a small number of high
quality, technically led advisers to the pharmaceutical and healthcare sectors”
Jim will be based at Cello Health’s BioConsulting Boston
office.
Ends
Cello Health
Cello Health consists of three distinct capabilities:
Cello Health
Insight: global marketing research and customer insight
Cello Health
Consulting: strategic consultancy
Cello Health
Communications: evidence and engagement
For further media information, please contact:Helen Lawn on +44 (0)1892 525141 or +44 (0)7879
818247, helen@helenlawn.co.uk; orAndy Newman on +44 (0)1603 465636 or +44 (0)7739
847964, andy@newmanassociates.co.ukNR54023/CH/310715
London, July 08, 2019 Cello Health GmbH opens in Berlin with its Business Insights and Analytics division, Cello Health Insight, appointing two regional directors: Heike Tombrink – Regional Director, Head of Cello Health Insight Germany, and Matthias Heurich – Regional Director, supporting Digital Innovation. Cello Health
Cello Health Insight in partnership with Janssen Pharmaceuticals has won EphMRA’s 2019 Market Research Excellence Award for 'Business Impact through Innovation'. Cello Health
Cello Health Logic offers pharmaceutical companies the ability to make sense of healthcare social media conversations and deliver actionable insights. Cello Health
Realising the full value of your asset – clinically and commercially – means thinking beyond the pure scientific value, even at the very early stages of development. Cello Health